PeterScottHeegerMD

Internal Medicine • New York, NY

Professor, Medicine, Icahn School of Medicine

Join to view full profile

Dr. Heeger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Heeger's full profile

Already have an account?

Office
1 Gustave L Levy Pl
Annenberg Bldg Box 1243
New York, NY 10029

Education & Training

Perelman School of Medicine at the University of PennsylvaniaClass of 1984

Certifications & Licensure

NY State Medical License 2007 - 2020
American Board of Internal Medicine Internal Medicine

Clinical Trials

Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients Start of enrollment: 2006 Mar 01
Completed
Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients Start of enrollment: 2007 Jun 01
Completed
Impact of Vitamin D Repletion in Hemodialysis Patients Start of enrollment: 2010 Aug 01
Completed
Not Applicable
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant Start of enrollment: 2011 Dec 01
Terminated
Phase 2
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation Start of enrollment: 2010 Nov 01
Terminated
Phase 2
Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation Start of enrollment: 2013 Jun 01
Terminated
Phase 2
Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function Start of enrollment: 2013 Jun 01
Unknown status
Phase 2
Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation Start of enrollment: 2013 Aug 01
Terminated
Phase 2
A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study Start of enrollment: 2013 Oct 01
Completed
Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study Start of enrollment: 2014 Oct 01
Completed
Join now to see all

Publications & Presentations

PubMed

36 citations
Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes
Zhongyang Zhang, Zeguo Sun, Jia Fu, Qisheng Lin, Khadija Banu
The Journal of Clinical Investigation. 2021-11-15
7 citations
T cell-derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death
Nicholas Chun, Rosalind L. Ang, Mark Chan, Robert L. Fairchild, William M. Baldwin
JCI Insight. 2021-11-09
2 citations
Two Can Be Better Than One: Improving Noninvasive Diagnostics in Kidney Transplantation.
Calla Khilnani, Peter S. Heeger
Clinical Journal of the American Society of Nephrology. 2021-10-01

Press Mentions

Infliximab May Lead to Higher Infection Rate, No Improvement in Transplant OutcomesJune 5th, 2022
Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results from Clinical Trials in Organ Transplantation-17November 20th, 2017
Protein-Based Urine Test Predicts Kidney Transplant OutcomesFebruary 10th, 2016
Join now to see all

Grant Support

Graft Rejection And Direct Versus Indirect RecognitionNational Institute Of Allergy And Infectious Diseases2010–2012
Individualizing Therapy For Kidney And Heart Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2010–2011
Cross-Disciplinary Postdoctoral Training Program In Transplant ResearchNational Institute Of Allergy And Infectious Diseases2010–2011
Complement And T Cell Mediated Allograft RejectionNational Institute Of Allergy And Infectious Diseases2010–2011
Individualizing Therapy For Kidney And Heart Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2009
Cross-Disciplinary Postdoctoral Training Program In Transplant ResearchNational Institute Of Allergy And Infectious Diseases2008–2009
Graft Rejection And Direct Versus Indirect RecognitionNational Institute Of Allergy And Infectious Diseases2007–2009
Complement And T Cell Mediated Allograft RejectionNational Institute Of Allergy And Infectious Diseases2007–2009
Noninvasive Markers And Transplant Outcome In HumansNational Institute Of Allergy And Infectious Diseases2006–2009
Graft Rejection And Direct Versus Indirect RecognitionNational Institute Of Allergy And Infectious Diseases2004–2006
Noninvasive Markers And Transplant Outcome In HumansNational Institute Of Allergy And Infectious Diseases2004–2005
Graft Rejection And Direct Versus Indirect RecognitionNational Institute Of Allergy And Infectious Diseases2001–2003
Graft Rejection And Direct Versus Indirect RecognitionNational Institute Of Allergy And Infectious Diseases1998–2000
Pilot--Cytokine Profiles And Skin Allograft ToleranceNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–1998
T Cell Help In Interstitial NephritisNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1996
Analysis Of T Cell Help In Interstitial NephritisNational Institute Of Diabetes And Digestive And Kidney Diseases1993
Analysis Of T Cell Help In Interstitial NephritisNational Institute Of Diabetes And Digestive And Kidney Diseases1992
T Cell Help In Interstitial NephritisNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1992

PeterScottHeegerMD

Dr. Heeger is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.